The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study
Open accessAbstract
Importance: Systemic inflammation and sarcopenia are easily evaluated, predict mortality in many cancers, and are potentially modifiable. The combination of inflammation and sarcopenia may be able to identify patients with early-stage colorectal cancer (CRC) with poor prognosis. Objective: To examine associations of prediagnostic systemic inflammation with at-diagnosis sarcopenia, and determine whether these factors interact to predict CRC survival, adjusting for age, ethnicity, sex, body mass index, stage, and cancer site. Design, Setting, and Participants: A prospective cohort of 2470 Kaiser Permanente patients with stage I to III CRC diagnosed from 2006 through 2011. Exposures: Our primary measure of inflammation was the neutrophil to lymphocyte ratio (NLR). We averaged NLR in the 24 months before diagnosis (mean count = 3 measures; mean time before diagnosis = 7 mo). The reference group was NLR of less than 3, indicating low or no inflammation. Main Outcomes and Measures: Using computed tomography scans, we calculated skeletal muscle index (muscle area at the third lumbar vertebra divided by squared height). Sarcopenia was defined as less than 52 cm2/m2 and less than 38 cm2/m2 for normal or overweight men and women, respectively, and less than 54 cm2/m2 and less than 47 cm2/m2 for obese men and women, respectively. The main outcome was death (overall or CRC related). Results: Among 2470 patients, 1219 (49%) were female; mean (SD) age was 63 (12) years. An NLR of 3 or greater and sarcopenia were common (1133 [46%] and 1078 [44%], respectively). Over a median of 6 years of follow-up, we observed 656 deaths, 357 from CRC. Increasing NLR was associated with sarcopenia in a dose-response manner (compared with NLR < 3, odds ratio, 1.35; 95% CI, 1.10-1.67 for NLR 3 to <5; 1.47; 95% CI, 1.16-1.85 for NLR ≥ 5; P for trend < .001). An NLR of 3 or greater and sarcopenia independently predicted overall (hazard ratio [HR], 1.64; 95% CI, 1.40-1.91 and HR, 1.28; 95% CI, 1.10-1.53, respectively) and CRC-related death (HR, 1.71; 95% CI, 1.39-2.12 and HR, 1.42; 95% CI, 1.13-1.78, respectively). Patients with both sarcopenia and NLR of 3 or greater (vs neither) had double the risk of death, overall (HR, 2.12; 95% CI, 1.70-2.65) and CRC related (HR, 2.43; 95% CI, 1.79-3.29). Conclusions and Relevance: Prediagnosis inflammation was associated with at-diagnosis sarcopenia. Sarcopenia combined with inflammation nearly doubled risk of death, suggesting that these commonly collected biomarkers could enhance prognostication. A better understanding of how the host inflammatory/immune response influences changes in skeletal muscle may open new therapeutic avenues to improve cancer outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Self-citationTempleton, A. J., McNamara, M. G., Šeruga, B., Vera-Badillo, F. E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J. J., Tran, B., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju124 · Cited by 2,829
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,680
Mourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224
Self-citationShen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692
Gupta, D., & Lis, C. G. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-69 · Cited by 1,485 · cited 2×
“5g/dL (thecutoff forhypoalbuminemia; to convert to grams per liter, multiply by 10).(14)”
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Fearon, K. C. H., Glass, D. J., & Guttridge, D. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,205
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Shachar, S. S., Williams, G. R., Muss, H. B., & Nishijima, T. F. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.12.030 · Cited by 1,099
NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia
Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C.-Y., & Baldwin Jr., A. S. (2000) · Science · doi:10.1126/science.289.5488.2363 · Cited by 924
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882 · cited 3×
“increased proteolysis, manifesting in decreasedmusclemass [sarcopenia], and increased lipiddeposition in skeletalmuscle [measured via CT muscle radiodensity]).(15) Although outside the scopeof this analysis, excess fatmayalsoplay a role in this vicious cycle:most of our patients were overweight or obese.”
InfluentialThe role of TNFα and TNF receptors in obesity and insulin resistance
Hotamisligil, G. S. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00490.x · Cited by 780
Templeton, A. J., Ace, O., McNamara, M. G., Al-Mubarak, M., Vera-Badillo, F. E., Hermanns, T., Šeruga, B., Ocaña, A., Tannock, I. F., & Amir, E. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0146 · Cited by 719
Srikanthan, P., Hevener, A. L., & Karlamangla, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010805 · Cited by 600 · cited 1×
“Increases in inflammatory cytokines can also lead to insulin resistance andmuscle wasting by activation of the ubiquitinproteasome proteolytic pathway,(36) while muscle loss itself further exacerbates insulin resistance.(37,38) Low-grade, systemic inflammationcausedbythe tumor (andexacerbatedpossibly byobesity or insu…”
Wang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E. (2006) · Endocrinology · doi:10.1210/en.2006-0251 · Cited by 600
Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer
Miyamoto, Y., Baba, Y., Sakamoto, Y., Ohuchi, M., Tokunaga, R., Kurashige, J., Hiyoshi, Y., Iwagami, S., Yoshida, N., Yoshida, M., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4281-6 · Cited by 361
Caan, B. J., Meyerhardt, J. A., Kroenke, C. H., Alexeeff, S., Xiao, J., Weltzien, E., Feliciano, E. C., Castillo, A. L., Quesenberry, C. P., Kwan, M. L., et al. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0200 · Cited by 354
Self-citationSarcopenia and cachexia in the era of obesity: clinical and nutritional impact
Prado, C. M., Cushen, S. J., Orsso, C. E., & Ryan, A. M. (2016) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115004279 · Cited by 300
Self-citationImpact of Resistance Training in Cancer Survivors: A Meta-Analysis
STRASSER, B., STEINDORF, K., WISKEMANN, J., & ULRICH, C. M. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31829a3b63 · Cited by 291
The emerging role of computerized tomography in assessing cancer cachexia
Prado, C. M., Birdsell, L. A., & Baracos, V. E. (2009) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0b013e328331124a · Cited by 274
Self-citationSarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer
Barret, M., Antoun, S., Dalban, C., Malka, D., Mansourbakht, T., Zaanan, A., Latko, E., & Taieb, J. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.894103 · Cited by 243
Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
Kantola, T., Klintrup, K., Väyrynen, J. P., Vornanen, J., Bloigu, R., Karhu, T., Herzig, K.-H., Näpänkangas, J., Mäkelä, J., Karttunen, T. J., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.456 · Cited by 241
Malietzis, G., Johns, N., Al-Hassi, H. O., Knight, S. C., Kennedy, R. H., Fearon, K. C. H., Aziz, O., & Jenkins, J. T. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001113 · Cited by 218
Jung, H.-W., Kim, J. W., Kim, J.-Y., Kim, S.-W., Yang, H. K., Lee, J. W., Lee, K.-W., Kim, D.-W., Kang, S.-B., Kim, K.-I., et al. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-014-2418-6 · Cited by 217
The prognostic value of neutrophil‐to‐lymphocyte ratio in colorectal cancer: A systematic review
Haram, A., Boland, M. R., Kelly, M. E., Bolger, J. C., Waldron, R. M., & Kerin, M. J. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24523 · Cited by 197
Joglekar, S., Nau, P. N., & Mezhir, J. J. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.24025 · Cited by 193
Differentiating Sarcopenia and Cachexia Among Patients With Cancer
Peterson, S. J., & Mozer, M. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533616680354 · Cited by 191
Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams
Kroenke, C. H., Neugebauer, R., Meyerhardt, J., Prado, C. M., Weltzien, E., Kwan, M. L., Xiao, J., & Caan, B. J. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0732 · Cited by 188
Self-citationGu, L., Li, H., Chen, L., Ma, X., Li, X., Gao, Y., Zhang, Y., Xie, Y., & Zhang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7876 · Cited by 178
Cancer-Associated Cachexia and Underlying Biological Mechanisms
Baracos, V. E. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111151 · Cited by 177
Ali, R., Baracos, V. E., Sawyer, M. B., Bianchi, L., Roberts, S., Assenat, E., Mollevi, C., & Senesse, P. (2016) · Cancer Medicine · doi:10.1002/cam4.621 · Cited by 177
Molecular mechanism of sarcopenia and cachexia: recent research advances
Sakuma, K., Aoi, W., & Yamaguchi, A. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1933-3 · Cited by 169
Richards, C. H., Roxburgh, C. S. D., MacMillan, M. T., Isswiasi, S., Robertson, E. G., Guthrie, G. K., Horgan, P. G., & McMillan, D. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041883 · Cited by 161
Padilha, C. S., Marinello, P. C., Galvão, D. A., Newton, R. U., Borges, F. H., Frajacomo, F., & Deminice, R. (2017) · Journal of Cancer Survivorship · doi:10.1007/s11764-016-0592-x · Cited by 149
Inflammatory burden and amino acid metabolism in cancer cachexia
Durham, W. J., Dillon, E. L., & Sheffield‐Moore, M. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32831cef61 · Cited by 138
The Effect of Resistance Exercise on All-Cause Mortality in Cancer Survivors
Hardee, J. P., Porter, R. R., Sui, X., Archer, E., Lee, I.-M. M., Lavie, C. J., & Blair, S. N. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.03.018 · Cited by 129
Regulation of skeletal-muscle–protein turnover in cancer-associated cachexia
Baracos, V. E. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00407-x · Cited by 127
Go, S., Park, M. J., Song, H., Kang, M. H., Park, H. J., Jeon, K. N., Kim, S., Kim, M. J., Kang, J.-H., & Lee, G. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2997-x · Cited by 118
Meyerhardt, J. A., Kroenke, C. H., Prado, C. M. M., Kwan, M. L., Castillo, A., Weltzien, E. K., Feliciano, E. M. C., Xiao, J., & Caan, B. J. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0145 · Cited by 86
Self-citationMetabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer
Feliciano, E. M. C., Kroenke, C. H., Meyerhardt, J. A., Prado, C. M. M., Bradshaw, P. T., Dannenberg, A. J., Kwan, M. L., Xiao, J., Quesenberry, C. P., Weltzien, E. K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.4473 · Cited by 84
Self-citationRole of n-3 fatty acids in muscle loss and myosteatosis
Ewaschuk, J. B., Al-Masud, A. A., & Mazurak, V. C. (2014) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2013-0423 · Cited by 62
Resistance exercise interventions during and following cancer treatment: a systematic review
Focht, B. C., Clinton, S. K., Devor, S. T., Garver, M. J., Lucas, A. R., Thomas‐Ahner, J. M., & Grainer, E. (2013) · The Journal of Supportive Oncology · doi:10.12788/j.suponc.0002 · Cited by 53
Müller, M. J., Baracos, V. E., Bosy‐Westphal, A., Dulloo, A. G., Eckel, J., Fearon, K. C. H., Hall, K. D., Pietrobelli, A., Sørensen, T. I. A., Speakman, J. R., et al. (2014) · Obesity Reviews · doi:10.1111/obr.12187 · Cited by 29
Cited by
Caan, B. J., Cespedes Feliciano, E. M., Prado, C. M., Alexeeff, S., Kroenke, C. H., Bradshaw, P., Quesenberry, C. P., Weltzien, E. K., Castillo, A. L., Olobatuyi, T. A., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0137 · Cited by 565
Self-citationPetrelli, F., Cortellini, A., Indini, A., Tomasello, G., Ghidini, M., Nigro, O., Salati, M., Dottorini, L., Iaculli, A., Varricchio, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.3520 · Cited by 530
Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients
Yamamoto, T., Kawada, K., & Obama, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158002 · Cited by 445
Economic Impact of Hospitalizations in US Adults with Sarcopenia
Goates, S., Du, K., Arensberg, M. B., Gaillard, T., Guralnik, J., & Pereira, S. L. (2019) · The Journal of Frailty & Aging · doi:10.14283/jfa.2019.10 · Cited by 297
Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance
Tuomisto, A. E., Mäkinen, M. J., & Väyrynen, J. P. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i31.4383 · Cited by 271
Metadata
- Authors
- Cespedes Feliciano, E. M., Kroenke, C. H., Meyerhardt, J. A., Prado, C. M., Bradshaw, P. T., Kwan, M. L., Xiao, J., Alexeeff, S., Corley, D., Weltzien, E., Castillo, A. L., & Caan, B. J.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-12-14
- Volume
- 3
- Issue
- 12
- Pages
- e172319
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2743199111
- Cited by
- 427
- References
- 43
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.